Initial filing by director officer or owner of more than ten percent.
This website is intended for a global audience.
Initial filing by director officer or owner of more than ten percent.
This section of the website is reserved for healthcare professionals as it contains information about prescription medicines. Please confirm you are a healthcare professional to continue.
We are closely monitoring our supply chain of EPIDIOLEX® (cannabidiol) and, at this time, do not foresee any supply interruptions in the United States.
At GW Pharmaceuticals, our main concern is the well-being of our patients, healthcare partners, and employees. Our hearts and thoughts go out to the people who have been affected. We are monitoring the COVID-19 situation and have taken steps to ensure that access and assistance for patients remain consistent.